Back to search

A mutation in CYP2C9 is responsible for decreased metabolism of losartan.

Stephen P. Spielberg, Jacqueline B. McCrea, Alastair E. Cribb, Tom Rushmore, Scott A. Waldman
DOI: 10.1038/sj.clpt.1996.361
Clinical Pharmacology & Therapeutics

Data up to Jan 2025

Published1996
Citations25
References0
Fields
ChemistryMedicineBiologyPharmacologyInternal medicineGenetics

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
A mutation in CYP2C9 is responsible for decreased metabolism of losartan. (1996) – Clinical Pharmacology & Therapeutics | Metascience Observatory Explorer